Skip to main content
. 2017 Jun 8;40(2):389–399. doi: 10.3892/ijmm.2017.3014

Figure 2.

Figure 2

(-)-Epigallocatechin gallate (EGCG) treatment alleviates cardiac dysfunction following ischemia/reperfusion (I/R) injury in diabetic rats. (A) Left ventricular systolic pressure (LVSP). (B) Maximum speed of pressure development in LV (+dp/dtmax). (C) Maximum speed of pressure decline (−dp/dtmax). Values are the means ± SEM, n=6. *P<0.05 vs. control group; #P<0.05 vs. DM + EGCG group.